Quick Answer
Legend Biotech Corp reported Research And Development Expense of $414.70 million for the year ending 2025.
- Legend Biotech Corp showed an increase of +0.3% in Research And Development Expense from 2024 to 2025.
- This data is from Legend Biotech Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Legend Biotech Corp's Research And Development Expense has grown by 583.9%.
- Historical annual values: Fiscal year 2025: $414.70 million | Fiscal year 2024: $413.50 million | Fiscal year 2023: $382.20 million | Fiscal year 2022: $335.65 million | Fiscal year 2021: $313.35 million | Fiscal year 2020: $232.16 million | Fiscal year 2019: $161.94 million | Fiscal year 2018: $60.64 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: